comparemela.com

Latest Breaking News On - Cantargia - Page 4 : comparemela.com

Cantargia AB: Cantargia reports first non-squamous NSCLC patient treated with nadunolimab, Keytruda and chemotherapy

LUND, Sweden, Sept. 22, 2022 /PRNewswire/ Cantargia (Cantargia AB) (Nasdaq: CANTA) (Stockholm: CANTA) today reported that the first patient has been treated in a new arm of the phase Ib clinical

Prnewswire cantargiaNasdaq stockholm

Cantargia AB: Cantargia: Oral presentation of new preclinical CAN10 efficacy data in systemic sclerosis at ACR Convergence

LUND, Sweden, Sept. 15, 2022 /PRNewswire/ Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today reported new preclinical data demonstrating efficacy of its anti-inflammatory IL1RAP-binding

United statesPrnewswire cantargiaHeinrich heine university hiller research centerNasdaq stockholmSystemic sclerosisRelated disorders

Cantargia AB: Cantargia presents preclinical data demonstrating unique treatment effects of nadunolimab on pancreatic cancer stromal cells

LUND, Sweden, Sept. 14, 2022 /PRNewswire/ Cantargia (Cantargia AB) (NASDAQ Stockholm: CANTA) today reported preclinical data for its lead candidate, the IL1RAP-binding antibody nadunolimab

United statesPrnewswire cantargiaLund universityPancreatic cancer action network panPancreatic cancerPancreatic cancer action network

Cantargia AB: New number of shares and votes in Cantargia

LUND, Sweden, Aug. 31, 2022 /PRNewswire/ The number of shares and votes in Cantargia AB (publ) has changed due to the recently completed rights issue (for further information, see the company's

Swedish financial instruments tradingNasdaq stockholm

Cantargia AB: Cantargia publishes half year report

LUND, Sweden, Aug. 30, 2022 /PRNewswire/ Cantargia AB's ("Cantargia") half year report for the period January until June 2022 is now available on the company's web page www.cantargia.com/en/investors/financial-reports. Significant

United statesUnited kingdomDominique tersagoTrademark officeCardiovascular sciences scientific sessionsEuropean atherosclerosis society congressEuropean atherosclerosis societyExtraordinary generalExtraordinary general meetingBasic cardiovascular sciences scientific sessionsUnited states patentChief medicalAbuse regulationSecurities marketNasdaq stockholm

vimarsana © 2020. All Rights Reserved.